Phase I Clinical Trials Program Lead

Sitcancer; Seattle (WA); On-site; USD 395,000 - 513,000; Full time

Benefits offered by this job

Relocation assistance

Sign-on bonus

Job summary

Fred Hutchinson Cancer Center in Seattle invites nominations and applications to head the Phase I Developmental Therapeutics clinical trials program. The Program Head will oversee early-phase trials, partnering with Fred Hutch’s immunotherapy and cell-based therapy groups, and collaborate with UW to align clinical research strategies.

This role blends academic leadership with clinical trial oversight, requiring a strong track record in Phase I research, collaboration, and translational science,

Qualifications

• MD/DO degree required or foreign equivalent.
• Board certification in medical oncology required or foreign equivalent.
• Eligibility for medical licensure in the state of Washington.

Responsibilities

• Design, implement, and manage early-phase clinical trials.
• Oversee selection and placement of phase I trials.
• Coordinate infrastructure for phase I studies (nurses, data coordinators, regulatory, tissue acquisition, biostatistical support).
• Collaborate with medical oncology and faculty to ensure patient accrual to studies.
• Direct care of a portion of study patients.
• Outreach to community oncology providers to improve access to Phase 1 trials.

Skills

Phase I research

Education

MD/DO degree

Board certification in medical oncology

Medical licensure eligibility (Washington)

Job description

Fred Hutchinson Cancer Center in Seattle invites nominations and applications to head the Phase I Developmental Therapeutics clinical trials program. The Program Head will oversee early-phase trials, partnering with Fred Hutch’s immunotherapy and cell-based therapy groups, and collaborate with UW to align clinical research strategies.

This role blends academic leadership with clinical trial oversight, requiring a strong track record in Phase I research, collaboration, and translational science,